insights_auto
Why is SRRK down 2.26%?
Dive Deeperchevron_right
SRRK:NASDAQ
Scholar Rock Holding Corp
$42.91
arrow_downward
-2.26%(-0.99) 1D
$42.91
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 2, 4:00:00 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SRRK...
Open
$44.13
High
$44.78
Low
$42.89
Mkt. cap
5.23B
Avg. vol.
1.87M
Volume
932.05K
52-wk high
$61.75
52-wk low
$27.07
EPS
-$3.32
Beta
0.61
Shares outstanding
121.78M
No. of employees
289
Open
$44.13
High
$44.78
Low
$42.89
Mkt. cap
5.23B
Avg. vol.
1.87M
Volume
932.05K
52-wk high
$61.75
52-wk low
$27.07
EPS
-$3.32
Beta
0.61
Shares outstanding
121.78M
No. of employees
289
News stories
From web sources and news partners
Foreign Policy Journal
·
35 minutes ago
RTX Corporation's (NYSE: RTX) $271 Billion Backlog Fuels Analyst Optimism Despite Engine Concerns
Dealroom
·
39 minutes ago
Agility Robotics clears SPAC vote, expects $465M and Nasdaq debut November 5
investingLive
·
8 minutes ago
JPMorgan’s four midterm scenarios: S&P 500 seen moving between -0.25% and +1.25%
Bloomberg.com
·
4 hours ago
Nasdaq 100 Enters Correction as Megacap Results Amplify AI Fears
About Scholar Rock Holding Corp
Analyst ratings
Based on 16 analysts giving stock ratings to SRRK in the past 3 months
Strong buy
Buy
15
Hold
1
Sell
0
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for SRRK in the last 3 months.
Highest
Current $42.91
$84.00 (+95.76%)
Average
$69.67 (+62.36%)
Lowest
$58.00 (+35.17%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Ritu Baral TD Cowen | Buy | Maintained | $71.00 | +65.5% | 10/21/2026 |
Allison Bratzel Piper Sandler | Buy | Maintained | $75.00 | +74.8% | 10/21/2026 |
Srikripa Devarakonda Truist Financial | Buy | Reiterated | $77.00 | +79.4% | 10/20/2026 |
Tazeen Ahmad Bank of America Securities | Buy | Maintained | - | - | 10/16/2026 |
Geoff Meacham Citi | Buy | Maintained | $74.00 | +72.5% | 10/15/2026 |
Unknown Analyst Leerink Partners | Buy | Maintained | $65.00 | +51.5% | 10/13/2026 |
Evan Seigerman BMO Capital | Buy | Reiterated | $84.00 | +95.8% | 10/12/2026 |
Etzer Darout Barclays | Hold | Maintained | $58.00 | +35.2% | 10/09/2026 |
David Nierengarten Wedbush | Buy | Maintained | $70.00 | +63.1% | 09/25/2026 |
Tessa Romero J.P. Morgan | Buy | Reiterated | $70.00 | +63.1% | 09/21/2026 |
Cory Kasimov Evercore ISI | Buy | Maintained | $72.00 | +67.8% | 09/15/2026 |
Andres Y. Maldonado H.C. Wainwright | Buy | Reiterated | $70.00 | +63.1% | 09/15/2026 |
Amy Li Jefferies | Buy | Maintained | $65.00 | +51.5% | 09/14/2026 |
Martin Auster Raymond James | Buy | Maintained | $72.00 | +67.8% | 09/14/2026 |
Michael Yee UBS | Buy | Maintained | $60.00 | +39.8% | 09/13/2026 |
Gary Nachman Canaccord Genuity | Buy | Reiterated | $62.00 | +44.5% | 08/12/2026 |
Unknown Analyst Wedbush | Buy | Maintained | $58.00 | +35.2% | 08/10/2026 |
Marc Frahm TD Cowen | Buy | Maintained | - | - | 08/09/2026 |
Unknown Analyst Canaccord Genuity | Buy | Initiated | $62.00 | +44.5% | 04/20/2026 |
Eric Schmidt FCA Cantor Fitzgerald | Buy | Maintained | - | - | 03/19/2026 |
Next call in 7 days
Tue, Nov 10, 8:00 AM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / -$0.84
Revenue / Est. (USD)
- / 283.67K
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | - | - | - | - |
Cost of goods sold | 50.49M | 46.88M | 51.81M | 58.23M |
Cost of revenue | 50.49M | 46.88M | 51.81M | 58.23M |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 53.06M | 45.02M | 50.20M | 50.67M |
Operating expense | 53.06M | 45.02M | 50.20M | 50.67M |
Total operating expenses | 103.55M | 91.90M | 102.02M | 108.90M |
Operating income | -103.55M | -91.90M | -102.02M | -108.90M |
Other non operating income | -69.00K | -61.00K | -790.00K | -570.00K |
EBT including unusual items | -102.22M | -90.96M | -105.51M | -109.90M |
EBT excluding unusual items | -102.22M | -90.96M | -102.17M | -109.90M |
Income tax expense | - | - | - | - |
Effective tax rate | - | - | - | - |
Other operating expenses | - | - | - | - |
Net income | -102.22M | -90.96M | -105.51M | -109.90M |
Net profit margin | - | - | - | - |
Earnings per share | -0.90 | -0.88 | -0.83 | -0.84 |
Interest and investment income | 2.73M | 3.53M | 2.94M | 4.09M |
Interest expense | -1.33M | -2.53M | -2.30M | -4.52M |
Net interest expenses | 1.40M | 992.00K | 633.00K | -425.00K |
Depreciation and amortization charges | - | - | - | - |
EBITDA | -103.13M | -91.47M | -101.68M | -108.60M |
Gain or loss from assets sale | - | - | 3.00K | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events